Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

Amgen and Synaffix sign licensing agreement worth up to $2bn

Amgen and Synaffix sign licensing agreement worth up to $2bn

The business model of Synaffix is target-specific technology out-licensing, shown through its existing deals with ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio, Kyowa Kirin, Genmab, Macrogenics and

Latest news

More from news
Approximately 1 fully matching, plus 242 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Saqib Islam brings experience from Alexion Pharmaceuticals. Cambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May. ... Islam said: “Already a clinical stage company, Moderna has

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 24 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
nzyme

The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...